SERIES B COMMON STOCK PURCHASE WARRANT ANAVEX LIFE SCIENCES CORP.Anavex Life Sciences Corp. • October 23rd, 2014 • Services-commercial physical & biological research
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, LINCOLN PARK CAPITAL FUND, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Anavex Life Sciences Corp., a Nevada corporation (the “Company”), up to 2,000,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued by the Company as of the date hereof pursuant to (i) Section 2.2 of the Securities Purchase Agreement, dated October 22, 2014, between the Company and the H
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 23rd, 2014 • Anavex Life Sciences Corp. • Services-commercial physical & biological research • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 22, 2014, by and between Anavex Life Sciences Corp., a Nevada corporation (the “Company”), and the purchaser identified on the signature page hereto (including its successors and assigns, the “Purchaser”).
